InvestorsHub Logo

misiu143

08/29/16 7:05 AM

#5649 RE: fred198484 #5645

You really don't know much.
Some patients on Pro 140 approaching 2 years on P 2b extension study, on monotherapy with excellent results.
And , no, no one need two Phase 3 study. One Phase 3 is enough .

Inoviorulez

08/30/16 7:16 PM

#5680 RE: fred198484 #5645

You do realize that the company is running both adjunct therapy -- combination and monotherapy right? That's two different phase 3 trials...... sigh for you.